These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 24239423)

  • 21. Phenotype and functionality of follicular helper T cells in patients with acute dengue infection.
    Wijesinghe A; Gamage J; Goonewardena H; Gomes L; Jayathilaka D; Wijeratne DT; de Alwis R; Jeewandara C; Wijewickrama A; Ogg GS; Malavige GN
    J Biomed Sci; 2020 Apr; 27(1):50. PubMed ID: 32264870
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Secretion of Galectin-9 as a DAMP during Dengue Virus Infection in THP-1 Cells.
    Dapat IC; Pascapurnama DN; Iwasaki H; Labayo HK; Chagan-Yasutan H; Egawa S; Hattori T
    Int J Mol Sci; 2017 Jul; 18(8):. PubMed ID: 28788062
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased serum levels of galectin-9 in patients with chikungunya fever.
    Gualberto Cavalcanti N; Melo Vilar K; Branco Pinto Duarte AL; Barreto de Melo Rêgo MJ; Pereira MC; da Rocha Pitta I; Diniz Lopes Marques C; Galdino da Rocha Pitta M
    Virus Res; 2020 Sep; 286():198062. PubMed ID: 32565125
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cytokine IP-10 and GM-CSF are prognostic biomarkers for severity in secondary dengue infection.
    Gowri Sankar S; Alwin Prem Anand A
    Hum Immunol; 2021 Jun; 82(6):438-445. PubMed ID: 33766427
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sequential waves of gene expression in patients with clinically defined dengue illnesses reveal subtle disease phases and predict disease severity.
    Sun P; García J; Comach G; Vahey MT; Wang Z; Forshey BM; Morrison AC; Sierra G; Bazan I; Rocha C; Vilcarromero S; Blair PJ; Scott TW; Camacho DE; Ockenhouse CF; Halsey ES; Kochel TJ
    PLoS Negl Trop Dis; 2013; 7(7):e2298. PubMed ID: 23875036
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association DENV1 and DENV2 infection with high serum levels of soluble thrombomodulin and VEGF in patients with dengue fever and dengue hemorrhagic fever.
    Del Moral-Hernández O; Martínez-Hernández NE; Mosso-Pani MA; Hernández-Sotelo D; Illades-Aguiar B; Flores-Alfaro E; Antonio-Vejar V; Leyva-Vázquez MA
    Int J Clin Exp Med; 2014; 7(2):370-8. PubMed ID: 24600491
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Markers of dengue disease severity.
    Srikiatkhachorn A; Green S
    Curr Top Microbiol Immunol; 2010; 338():67-82. PubMed ID: 19802579
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum metabolome changes in adult patients with severe dengue in the critical and recovery phases of dengue infection.
    Cui L; Pang J; Lee YH; Ooi EE; Ong CN; Leo YS; Tannenbaum SR
    PLoS Negl Trop Dis; 2018 Jan; 12(1):e0006217. PubMed ID: 29364889
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neutrophil Activation and Early Features of NET Formation Are Associated With Dengue Virus Infection in Human.
    Opasawatchai A; Amornsupawat P; Jiravejchakul N; Chan-In W; Spoerk NJ; Manopwisedjaroen K; Singhasivanon P; Yingtaweesak T; Suraamornkul S; Mongkolsapaya J; Sakuntabhai A; Matangkasombut P; Loison F
    Front Immunol; 2018; 9():3007. PubMed ID: 30687301
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A clinical and epidemiological survey of the largest dengue outbreak in Southern Taiwan in 2015.
    Wang WH; Lin CY; Chang K; Urbina AN; Assavalapsakul W; Thitithanyanont A; Lu PL; Chen YH; Wang SF
    Int J Infect Dis; 2019 Nov; 88():88-99. PubMed ID: 31521850
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A prospective nested case-control study of Dengue in infants: rethinking and refining the antibody-dependent enhancement dengue hemorrhagic fever model.
    Libraty DH; Acosta LP; Tallo V; Segubre-Mercado E; Bautista A; Potts JA; Jarman RG; Yoon IK; Gibbons RV; Brion JD; Capeding RZ
    PLoS Med; 2009 Oct; 6(10):e1000171. PubMed ID: 19859541
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of IFN-Y +874 T/A polymorphism on clinical manifestations of dengue: a meta-analysis.
    Kaur G; Gupta K; Singh A; Kumar N; Banerjee I
    J Genet; 2021; 100():. PubMed ID: 34984984
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical Proteomics and Cytokine Profiling for Dengue Fever Disease Severity Biomarkers.
    Jadhav M; Nayak M; Kumar S; Venkatesh A; Patel SK; Kumar V; Sharma S; Samanta B; Deb S; Karak A; Verma S; Talukdar A; Kochar SK; Mansukhani P; Gandhi M; Srivastava S
    OMICS; 2017 Nov; 21(11):665-677. PubMed ID: 29091011
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Determination of viremia and concentration of circulating nonstructural protein 1 in patients infected with dengue virus in Mexico.
    de la Cruz-Hernández SI; Flores-Aguilar H; González-Mateos S; López-Martinez I; Alpuche-Aranda C; Ludert JE; del Angel RM
    Am J Trop Med Hyg; 2013 Mar; 88(3):446-54. PubMed ID: 23339203
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differences in activation and tissue homing markers of natural killer cell subsets during acute dengue infection.
    Keawvichit R; Khowawisetsut L; Lertjuthaporn S; Tangnararatchakit K; Apiwattanakul N; Yoksan S; Chuansumrit A; Chokephaibulkit K; Ansari AA; Onlamoon N; Pattanapanyasat K
    Immunology; 2018 Apr; 153(4):455-465. PubMed ID: 29105052
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relationship between circulating vascular endothelial growth factor and its soluble receptors in adults with dengue virus infection: a case-control study.
    Seet RC; Chow AW; Quek AM; Chan YH; Lim EC
    Int J Infect Dis; 2009 Sep; 13(5):e248-53. PubMed ID: 19261502
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Maintenance of demographic and hematological profiles in a long-lasting dengue fever outbreak: implications for management.
    Dos Santos Carmo AM; Suzuki RB; Riquena MM; Eterovic A; Sperança MA
    Infect Dis Poverty; 2016 Sep; 5(1):84. PubMed ID: 27593529
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metabolomics-Based Discovery of Small Molecule Biomarkers in Serum Associated with Dengue Virus Infections and Disease Outcomes.
    Voge NV; Perera R; Mahapatra S; Gresh L; Balmaseda A; Loroño-Pino MA; Hopf-Jannasch AS; Belisle JT; Harris E; Blair CD; Beaty BJ
    PLoS Negl Trop Dis; 2016 Feb; 10(2):e0004449. PubMed ID: 26913918
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Innate Immune Cytokine Profiling and Biomarker Identification for Outcome in Dengue Patients.
    Pradeep SP; Hoovina Venkatesh P; Manchala NR; Vayal Veedu A; Basavaraju RK; Selvasundari L; Ramakrishna M; Chandrakiran Y; Krishnamurthy V; Holigi S; Thomas T; Ross CR; Dias M; Satchidanandam V
    Front Immunol; 2021; 12():677874. PubMed ID: 34335578
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Micronutrients, Immunological Parameters, and Dengue Virus Infection in Coastal Ecuador: A Nested Case-Control Study in an Infectious Disease Surveillance Program.
    Finkelstein JL; Colt S; Layden AJ; Krisher JT; Stewart-Ibarra AM; Polhemus M; Beltrán-Ayala E; Tedesco JM; Cárdenas WB; Endy T; Mehta S
    J Infect Dis; 2020 Jan; 221(1):91-101. PubMed ID: 31428794
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.